Melinta Therapeutics Inc | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (13)

View All

Latest Posts

About This Stock More About This Stock
Melinta Therapeutics Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, May 24, 2018 1:35 AM EDT
Melinta Therapeutic announced the pricing of an underwritten public offering of 22,000,000 shares of its common stock at $5.00 per share, before underwriting discounts and commissions.
In this article: MLNT
Read
4 Biotech Stocks To Watch In The New Year
Article By: Zacks Investment Research
Sunday, January 7, 2018 5:23 PM EDT
Biotech companies are continuously working on bringing innovative new treatments to market, and there could be significant catalysts in the coming quarters in the form of important product approvals as well as major data read-outs.
In this article: EBS, GSK, MDCO, XOMA, EXEL, NVS, MLNT
Read
All Posts

Latest Tweets for $MLNT

No tweets yet!

PARTNER HEADLINES